We recently participated in Mediaplanet’s Fighting Alzheimer’s campaign where we united with like minded industry leaders to raise awareness about the need for increased funding for research, how to better the lives of those living with Alzheimer’s and how to assist their families and caregivers. The campaign was distributed through USA TODAY on November 28th …
VIDEO: Dr. Michael Mason explores various benefits of dementia medications, such as improved cognition, memory, behavior and lifespan. See the stages at which they are most effective.
CARE TIPS VIDEO: Delusions and hallucinations in dementia can trigger paranoia. This leads to challenging behaviors, such as false accusations of theft. Wandering can be especially frightening, striking 60% of people with Alzheimer’s. Check out these tips to minimize and care for these challenges.
BBC VIDEO: A new era in Alzheimer’s research is dawning that suggests we are the cusp of a cure. Watch BBC’s full program.
By Alzheimer’s Prevention Bulletin Our October expert is Deborah Blacker, MD, ScD, Professor of Psychiatry at Harvard Medical School and Professor and Deputy Chair, Epidemiology at the Harvard T.H. Chan School of Public Health. Dear Dr. Blacker, I understand that memory games and crossword puzzles are supposed to be good for your brain health. But …
What’s a 10 Letter Word for Maintaining Your Brain? E-n-g-a-g-e-m-e-n-t For Deborah Blacker, MD, ScD, and her colleagues, brain health and dementia prevention is serious business, but they can sum up a portion of their recent research findings with a humorous anecdote. “A colleague of mine who worked on the study shared this, ‘A patient …
Watch the recording as Dr. Pierre N. Tariot, Director of the Banner Alzheimer’s Institute, discusses the latest research into Alzheimer’s treatment and prevention. In this recording, he examines what we know about Alzheimer’s , including the role of genes in its development. He also talks about risk factors for the disease, important new studies currently …
DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look into the exploratory, open label Phase 2a study. In an open-label exploratory study, 36 subjects with mild to moderate disease (MMSE 14-26) were randomized to receive 1 of 4 doses …
Phase 2b Trial Showed Positive Results In Slowing Cognitive Decline High Point, North Carolina (September 7, 2016) vTv Therapeutics Inc. (NASDAQ:VTVT) today announced the completion of enrollment for Part A of STEADFAST (Single Trial Evaluating Alzheimer’s Disease Following Addition to Symptomatic Therapy), vTv’s Phase 3 placebo-controlled trial of azeliragon, an oral antagonist of the Receptor …
Before a medicine can be mass produced to help others in need, we must go to the very beginning to fully understand the amount of work and effort put in to create a medicine. It begins with an idea, an inspiration which leads scientists to go to work. Thousands of sleepless nights and several years …
For those who are struggling with memory loss, a memory screen is a step in the right direction to keeping their minds healthy. Apply for a FREE memory screen today!
